# CDSCO

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/cdsco
Canonical HTML page: https://gethealthbrief.com/entity/cdsco

## Timeline

- **2027-01-01**: Implementation Phase — Expected start of streamlined registration for priority therapeutic categories.
- **2026-06-15**: Technical Working Group (Projected) — First meeting of regulatory experts to define GMP inspection sharing protocols.
- **2026-Q2 (projected)**: Prescription Crackdown — Expected implementation of stricter digital prescription tracking for GLP-1 medications.
- **2026-03-24**: Regulatory Warning — India's CDSCO issues a formal alert regarding the misuse of affordable weight-loss jabs.
- **2026-02-22**: Bilateral Briefing — Government representatives outline the scope of pharmaceutical and medical product alignment.
- **2026-02-21**: MoU Exchange — Official documents exchanged between India and Brazil to initiate regulatory cooperation.
- **2025-Q2**: Generic Entry — Indian pharmaceutical firms begin ramping up production of low-cost semaglutide biosimilars.
- **2024-Q4**: Global Shortages — High demand for GLP-1 drugs in Western markets leads to global supply constraints.

## Recent coverage (3 stories)

### India Issues Regulatory Alert Over Misuse of Low-Cost GLP-1 Weight-Loss Jabs
2026-03-24 15:07:58 · Sentiment: Negative · Impact: 6/10 · Sources: 2

Indian health authorities have issued a formal warning regarding the rising misuse of affordable weight-loss injections, highlighting risks associated with unsupervised administration. As the domestic market for GLP-1 receptor agonists expands, regulators are moving to curb off-label cosmetic use that threatens public health and drug availability for diabetic patients.
Full story: https://gethealthbrief.com/story/india-weight-loss-jab-misuse-warning

### AIOCD Opposes Drug Licenses for Primary Agricultural Credit Societies (PACS)
2026-03-06 06:53:49 · Sentiment: Negative · Impact: 6/10 · Sources: 2

The All India Organisation of Chemists and Druggists (AIOCD) has launched a formal protest against a government proposal to allow Primary Agricultural Credit Societies (PACS) to operate pharmacies. The AIOCD argues that these cooperative societies lack the technical expertise and infrastructure required to safely dispense medications, potentially endangering public health.
Full story: https://gethealthbrief.com/story/aiocd-opposes-pacs-drug-licenses-india

### India and Brazil Ink Regulatory Pact to Streamline Pharma and MedTech Trade
2026-02-22 12:32:48 · Sentiment: Positive · Impact: 6/10 · Sources: 2

India and Brazil have formalized a Memorandum of Understanding (MoU) to harmonize the regulation of pharmaceutical and medical products. This strategic partnership aims to enhance bilateral cooperation, streamline market entry for life sciences companies, and ensure the safety and efficacy of medical goods exchanged between the two major emerging economies.
Full story: https://gethealthbrief.com/story/india-brazil-pharma-regulatory-mou-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.